Preventing oncology drug resistance
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
89
NCT06048770
A Study of RBI-4000 in Healthy Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 1, 2023
Completion: Jul 31, 2024
Loading map...